Ken Griffin Medical Devices

Citadel Advisors LLC

$509 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
SMLR Semler Scientific, Inc.	$286M	$538,000 0.0% of portfolio	14,879	Q1 2025 Added 33.67%
SGHT Sight Sciences, Inc.	$166M	$530,000 0.0% of portfolio	220,958	Q1 2025 Reduced 12.02%
ICAD Icad Inc	$94.5M	$479,000 0.0% of portfolio	232,713	Q1 2025 Added 438.4%
STE Steris PLC	$23.1B	$444,000 0.0% of portfolio	1,962	Q1 2025 Reduced 62.34%
PROF Profound Medical Corp.	$126M	$420,000 0.0% of portfolio	72,321	Q1 2025 Added 56.91%
ELMD Electromed, Inc.	$170M	$388,000 0.0% of portfolio	16,302	Q1 2025 Added 965.49%
KIDS Orthopediatrics Corp	$486M	$344,000 0.0% of portfolio	13,976	Q1 2025 Reduced 75.15%
IRTC I Rhythm Technologies, Inc.	$3.99B	$324,000 0.0% of portfolio	3,102	Q1 2025 Reduced 98.98%
AORT Artivion, Inc.	$1.24B	$267,000 0.0% of portfolio	10,876	Q1 2025 New
PHG Koninklijke Philips Nv	$21.4B	$224,000 0.0% of portfolio	8,851	Q1 2025 Reduced 77.96%
VMD Viemed Healthcare, Inc.	$268M	$181,000 0.0% of portfolio	24,867	Q1 2025 Reduced 46.58%
LUCD Lucid Diagnostics Inc.	$40.9M	$180,000 0.0% of portfolio	121,430	Q1 2025 Added 1.29%
EDAP Edap Tms Sa	$57.8M	$168,000 0.0% of portfolio	86,119	Q1 2025 Added 32.0%
ARAY Accuray Inc	$130M	$154,000 0.0% of portfolio	86,260	Q1 2025 Reduced 65.12%
CLPT Clear Point Neuro, Inc.	$284M	$145,000 0.0% of portfolio	12,209	Q1 2025 Reduced 51.51%
IINN Inspira Technologies Oxy B.H.N. LTD	$16.5M	$128,000 0.0% of portfolio	192,237	Q1 2025 Added 121.57%
ZIMV Zim Vie Inc.	$267M	$118,000 0.0% of portfolio	10,972	Q1 2025 Reduced 73.3%
TELA Tela Bio, Inc.	$40.2M	$80,000 0.0% of portfolio	66,006	Q1 2025 Added 16.8%
IRIX Iridex Corp	$15.3M	$73,000 0.0% of portfolio	74,248	Q1 2025 Added 9.75%
NVNO En V Veno Medical Corp	$37.6M	$69,000 0.0% of portfolio	26,421	Q1 2025 Reduced 75.15%
TCMD Tactile Systems Technology Inc	$202M	$66,000 0.0% of portfolio	5,013	Q1 2025 Reduced 74.8%
CODX Co Diagnostics, Inc.	$9.8M	$58,000 0.0% of portfolio	189,119	Q1 2025 Added 1,048.54%
XTNT Xtant Medical Holdings, Inc.	$72.5M	$44,000 0.0% of portfolio	94,115	Q1 2025 New
NVRO Nevro Corp	$207M	$35,000 0.0% of portfolio	6,032	Q1 2025 Reduced 98.99%
APYX Apyx Medical Corp	$89.9M	$18,000 0.0% of portfolio	13,566	Q1 2025 Reduced 79.56%
CTSO Cytosorbents Corp	$46.2M	$8,000 0.0% of portfolio	8,183	Q1 2025 New
NMTC Neuroone Medical Technologies Corp	$12M	$8,000 0.0% of portfolio	10,107	Q1 2025 Reduced 87.64%
LNSR Lensar, Inc.	$145M	$0 0.0% of portfolio	28	Q1 2025 Reduced 99.74%
PACB Pacific Biosciences Of California, Inc.	$333M	$0 0.0% of portfolio	22	Q1 2025 Reduced 99.99%

Shares Options

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Ken Griffin's portfolio

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account